一种新的前列腺癌药物在英国的供应情况参差不齐，尽管已获得批准，但仍形成了“邮政编码彩票”。 A new prostate cancer drug is unevenly available in the UK, creating a 'postcode lottery' despite approval.

一个慈善组织警告说,在英国,获得一种新的前列腺癌症药物的机会仍然不均衡,尽管治疗已获批准,但病人仍面临着基于其居住地点的“彩票邮票”问题。 A charity warns that access to a new prostate cancer drug in the UK remains uneven, with patients facing a 'postcode lottery' based on where they live, despite the treatment being approved. 这种药物为晚期病例带来了希望,但并非所有区域都能持续提供,使人们对公平获得救生治疗的机会感到关切。 The drug, which offers hope for advanced cases, is not yet consistently available across all regions, raising concerns about equitable access to life-saving treatments.